US · COO
The Cooper Companies, Inc.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- San Ramon, CA 94583
- Website
- coopercos.com
Price · as of 2025-10-31
$62.36
Market cap 16.63B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $69.89 | +12.08% |
| Intrinsic Value(DCF) | $33.38 | -46.47% |
| Graham-Dodd Method(GD) | $31.30 | -49.81% |
| Graham Formula(GF) | $24.21 | -61.18% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $17.38 | $40.58 | $0.00 | $7.97 | $20.84 |
| 2012 | $24.14 | $43.08 | $0.00 | $10.55 | $21.19 |
| 2013 | $31.45 | $47.44 | $0.00 | $12.62 | $26.66 |
| 2014 | $40.38 | $47.93 | $0.00 | $8.61 | $22.42 |
| 2015 | $32.12 | $40.47 | $0.00 | $7.45 | $13.15 |
| 2016 | $44.24 | $47.22 | $0.00 | $9.57 | $24.18 |
| 2017 | $57.56 | $58.10 | $0.00 | $13.51 | $31.55 |
| 2018 | $65.32 | $59.39 | $16.03 | $8.00 | $18.33 |
| 2019 | $83.36 | $65.64 | $0.00 | $17.69 | $30.11 |
| 2020 | $90.76 | $62.69 | $0.00 | $12.85 | $0.12 |
| 2021 | $102.13 | $123.23 | $2.04 | $96.58 | $409.93 |
| 2022 | $86.28 | $65.63 | $0.57 | $27.63 | $40.61 |
| 2023 | $91.48 | $72.38 | $0.00 | $27.03 | $24.30 |
| 2024 | $90.31 | $77.29 | $0.00 | $31.20 | $31.88 |
| 2025 | $83.45 | $69.89 | $0.00 | $31.30 | $24.21 |
AI valuation
Our deep-learning model estimates The Cooper Companies, Inc.'s (COO) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $69.89
- Current price
- $62.36
- AI upside
- +12.08%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$33.38
-46.47% upside
Graham-Dodd
$31.30
-49.81% upside
Graham Formula
$24.21
-61.18% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| COO | The Cooper Companies, Inc… | $62.36 | 16.63B | +12% | -46% | -50% | -61% | 44.52 | 2.03 | 4.08 | 18.38 | — | 5.96 | 60.67% | 16.69% | 9.16% | 4.59% | 4.21% | 3.03% | 0.34 | 6.83 | 1.89 | 0.84 | 2.54 | -459.00% | 506.00% | 5054.00% | 2.60% | 0.72 | 4.04% | 0.00% | 0.00% | 1.74% | 28.35 | 44.65 | 4.73 | 3.88 |
| DOCS | Doximity, Inc. | $24.53 | 4.61B | +213% | +46% | -54% | +33% | 49.27 | 10.16 | 19.28 | 41.92 | 90.95 | 11.09 | 90.20% | 39.94% | 39.13% | 22.50% | 116.06% | 19.05% | 0.01 | — | 6.97 | 6.68 | -0.82 | 5417.00% | 1998.00% | 4961.00% | 2.43% | 1.75 | 160.49% | 0.00% | 0.00% | 2.14% | 44.30 | 37.84 | 17.69 | 38.45 |
| FMS | Fresenius Medical Care AG… | $23.46 | 13.52B | -1% | -60% | +12% | -19% | 11.94 | 0.82 | 0.60 | 7.06 | 14.46 | -21.51 | 25.62% | 9.31% | 4.98% | 6.78% | 6.03% | 3.03% | 0.76 | — | 1.26 | 0.76 | 3.11 | 8261.00% | 151.00% | 54.00% | 14.52% | 0.41 | 7.11% | 3.47% | 41.50% | 13.67% | 11.43 | 12.31 | 1.06 | 1.31 |
| HOLX | Hologic, Inc. | $75.36 | 16.82B | +9% | -53% | -75% | -67% | 30.11 | 3.37 | 4.15 | 17.05 | — | 20.82 | 61.00% | 17.42% | 13.80% | 11.12% | 10.86% | 6.23% | 0.52 | 16.73 | 3.75 | 2.87 | 0.65 | -2500.00% | 174.00% | -1964.00% | 5.40% | 1.08 | 16.84% | 0.00% | 0.00% | 4.42% | 24.44 | 18.97 | 4.26 | 4.18 |
| ICLR | ICON Public Limited Compa… | $108.14 | 8.26B | +89% | -31% | -50% | -11% | 19.44 | 1.62 | 1.86 | 11.80 | 67.55 | -4.98 | 29.42% | 13.26% | 9.56% | 8.44% | 7.88% | 4.67% | 0.38 | 4.63 | 1.26 | 1.21 | 1.96 | 2878.00% | 199.00% | 963.00% | 7.27% | 0.46 | 8.81% | 0.00% | 0.00% | 6.47% | 16.81 | 16.50 | 2.23 | 2.24 |
| NBIX | Neurocrine Biosciences, I… | $132.25 | 13.27B | +32% | +46% | -57% | +4% | 27.52 | 4.05 | 4.60 | 18.16 | 65.61 | 4.05 | 98.18% | 21.64% | 16.73% | 16.38% | 20.21% | 11.46% | 0.13 | — | 3.39 | 2.92 | -0.45 | 4195.00% | 2145.00% | 3437.00% | 5.68% | 1.05 | 36.02% | 0.00% | 0.00% | 5.22% | 19.56 | 16.17 | 4.23 | 7.39 |
| SMMT | Summit Therapeutics Inc. | $16.59 | 12.35B | — | — | — | — | -11.21 | 18.37 | — | -14.24 | -3.08 | 18.43 | 0.00% | — | — | -206.10% | 2928.71% | -181.94% | 0.02 | — | 9.87 | 9.77 | 0.26 | 36452.00% | — | 12749.00% | -2.67% | -4.42 | 1166.77% | 0.00% | 0.00% | 0.93% | -14.04 | -35.25 | — | 72.96 |
| SNN | Smith & Nephew plc | $36.90 | 16.13B | +1% | -68% | — | -68% | 30.99 | 2.43 | 2.20 | 12.51 | — | 10.58 | 69.64% | 11.31% | 7.09% | 7.86% | 6.81% | 4.05% | 0.63 | 3.91 | 2.89 | 1.19 | 2.18 | -2167.00% | 470.00% | 23481.00% | 4.75% | 0.64 | 7.59% | 2.56% | 79.40% | 3.19% | 23.55 | 25.53 | 2.66 | 3.29 |
| SOLV | Solventum Corporation | $74.20 | 12.87B | +72% | -56% | -45% | +7% | 8.17 | 2.52 | 1.53 | 6.62 | 3.68 | -3.91 | 53.47% | 26.20% | 18.69% | 38.86% | 20.41% | 10.82% | 1.00 | 6.29 | 1.23 | 0.61 | 1.63 | 22174.00% | 86.00% | -10124.00% | -0.08% | 0.12 | -0.10% | 0.00% | 0.00% | 24.32% | 7.73 | -1686.63 | 2.03 | 2.15 |
| TEM | Tempus AI, Inc. | $53.25 | 9.2B | +3% | +24,028% | — | — | -37.91 | 18.91 | 7.30 | -42.05 | — | -27.80 | 69.64% | -18.76% | -19.27% | -89.48% | -62.74% | -15.31% | 1.66 | -3.40 | 3.13 | 2.86 | -0.95 | -6937.00% | 8341.00% | 1325.00% | -2.57% | -0.59 | -76.13% | 0.00% | 0.00% | 0.03% | -39.18 | -39.10 | 7.35 | 3.76 |
| UHS | Universal Health Services… | $206.10 | 13.12B | -29% | -58% | -24% | +99% | 8.68 | 1.80 | 0.76 | 6.73 | 23.26 | 3.99 | 11.48% | 11.48% | 8.57% | 21.68% | 12.66% | 10.08% | 0.76 | 12.68 | 1.05 | 0.85 | 1.95 | 3734.00% | 971.00% | -2440.00% | 6.47% | 0.58 | 7.04% | 0.39% | 3.40% | 7.77% | 9.27 | 21.78 | 1.07 | 3.24 |
About The Cooper Companies, Inc.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
- CEO
- Albert G. White
- Employees
- 16K
- Beta
- 1.03
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($33.38 ÷ $62.36) − 1 = -46.47% (DCF, example).